Mirror Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MIRROR PHARMS, and what generic and branded alternatives to MIRROR PHARMS drugs are available?
MIRROR PHARMS has two approved drugs.
Drugs and US Patents for Mirror Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mirror Pharms Llc | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 040883-001 | Dec 23, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mirror Pharms | PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN | acetaminophen; propoxyphene napsylate | TABLET;ORAL | 077821-001 | Feb 11, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.